Jade Biosciences (JBIO) Change in Acquisitions & Divestments (2022 - 2026)

Jade Biosciences' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $65.4 million for Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 409.17% year-over-year to $65.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $112.4 million (up 72.99% YoY) and the FY2025 annual result came in at $14.4 million, down 80.96% from the prior year.
• Change in Acquisitions & Divestments was $65.4 million for Q1 2026 at Jade Biosciences, up from $12.8 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $65.4 million in Q1 2026 and bottomed at $12.5 million in Q1 2022.
• A 5-year average of $31.8 million and a median of $30.6 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments plunged 60.81% — and 2026, when it soared 409.17%.
• Jade Biosciences' Change in Acquisitions & Divestments stood at $64.8 million in 2022, then plunged by 48.26% to $33.5 million in 2023, then sank by 60.81% to $13.1 million in 2024, then retreated by 2.13% to $12.8 million in 2025, then surged by 409.17% to $65.4 million in 2026.
• Business Quant data shows JBIO's Change in Acquisitions & Divestments at $65.4 million in Q1 2026, $12.8 million in Q1 2025, and $13.1 million in Q4 2024.